Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CLDI

Calidi Biotherapeutics Inc

Last Close
Dec 08 • 04:00PM ET
2.13
Dollar change
-0.19
Percentage change
-8.19 		%
Scroll to Statements
Index- P/E- EPS (ttm)-0.90 Insider Own51.22% Shs Outstand4.13M Perf Week-2.74%
Market Cap8.80M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.01M Perf Month4.41%
Income-8.59M PEG- EPS next Q-0.20 Inst Own43.35% Short Float / Ratio0.90% / 0.31 Perf Quarter-74.88%
Sales0.00M P/S- EPS this Y- Inst Trans-89.74% Short Interest0.02M Perf Half Y-79.36%
Book/sh3.16 P/B0.67 EPS next Y- ROA-6.24% Target Price10.00 Perf Year-78.64%
Cash/sh0.16 P/C13.13 EPS next 5Y- ROE-6.81% 52W Range1.50 - 13.79 Perf YTD-79.06%
Dividend- P/FCF6.24 EPS past 5Y- ROI-27.48% 52W High-84.55% Beta0.57
Dividend %- Quick Ratio0.10 Sales past 5Y0.00% Gross Margin- 52W Low42.00% ATR0.33
Employees2 Current Ratio0.10 Sales Q/Q- Oper. Margin0.00% RSI (14)48.35 Volatility18.15% 14.28%
OptionableNo Debt/Eq0.05 EPS Q/Q-398.62% Profit Margin- Rel Volume1.51 Prev Close2.32
ShortableYes LT Debt/Eq0.00 EarningsNov 14 AMC Payout0.00% Avg Volume58.45K Price2.13
Recom1.50 SMA206.42% SMA50-10.90% SMA200-72.68% Volume88,240 Change-8.19%
Date Action Analyst Rating Change Price Target Change
Nov-22-23Initiated H.C. Wainwright Buy $11
Oct-09-23Initiated Robert W. Baird Outperform $9
Nov-20-23 07:00AM
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones
(Business Wire)
Nov-14-23 04:05PM
Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results
(Business Wire) -6.98%
Nov-03-23 07:00AM
Calidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancers 38th Annual Meeting (SITC 2023)
(Business Wire) +18.90%
Nov-01-23 07:00AM
Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment
(Business Wire) -10.55%
Oct-30-23 07:00AM
Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer
(Business Wire) -13.19%
07:00AM Loading…
Oct-10-23 07:00AM
Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023
(Business Wire)
Sep-13-23 05:50AM
Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies
(GlobeNewswire) -38.75%
Sep-11-23 04:05PM
First Light Acquisition Group Announces NYSE Approval for Listing of Business Combination with Calidi Biotherapeutics and Additional New Capital Commitments
(GlobeNewswire)
Aug-24-23 12:06PM
FIRST LIGHT ACQUISITION GROUP, INC. Further Adjourns Special Meeting of Stockholders to August 28, 2023 at 10:30 am ET
(GlobeNewswire)
Aug-22-23 11:41AM
FIRST LIGHT ACQUISITION GROUP, INC. Adjourns Special Meeting of Stockholders to August 24, 2023 at 10:30 am ET
(GlobeNewswire) -10.85%
Aug-16-23 06:00AM
Flag Stockholders: Reminder to Vote for Proposed Business Combination
(GlobeNewswire)
Aug-07-23 05:00AM
First Light Acquisition Group, Inc. Announces Effectiveness of Registration Statement and Sets August 22, 2023 as Date of Stockholder Meeting for the Calidi Business Combination
(GlobeNewswire)
Jun-23-23 05:00AM
Calidi Biotherapeutics Announces Commitment of $25 Million in Series B Funding to Advance Stem Cell-Based Platforms for the Delivery and Potentiation of Oncolytic Viruses to Treat Cancer
(GlobeNewswire)
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company is headquartered in San Diego, CA.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2023 FINVIZ.com. All Rights Reserved.